PF4 and allergic asthma: An increasing body of evidence suggests that in patients with allergic asthma, platelet-specific derived mediators such as platelet factor 4 (PF4) and beta-thromboglobulin (β-TG) increase in the serum, indicating platelet activation (13–20).